Results 111 to 120 of about 2,302,356 (314)

Cell Therapy for Neurological Disorders: The Perspective of Promising Cells

, 2021
Neurological disorders are big public health challenges that are afflicting hundreds of millions of people around the world. Although many conventional pharmacological therapies have been tested in patients, their therapeutic efficacies to alleviate ...
Xin-Fu Zhou, Donghui Liu, Larisa Bobrovskaya, Bobrovskaya, L., Liu, D., Zhou, X.F.   +5 more
core   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva   +6 more
wiley   +1 more source

Sexual dysfunction in neurological disorders [PDF]

, 1983
Boller, François & Frank, Ellen. Sexual dysfunction in neurological disorders. Diagnosis, management and reabilitation.
Nogueira, Ivette Teixeira Chagas
core  

Neurological disorders in patients with acute thallium poisoning

, 2019
The largest study on neurological disorders in patients with laboratory-confirmed acute thallium poisoning was conducted in State Budgetary Healthcare Institution N.V.Sklifosovsky Research Institute of Emergency Medicine of Moscow Department of Health ...
Anastasiya Yu. Simonova, Yuriy N. Ostapenko, Sergey S. Petrikov, Marina G. Gadzhieva, Lesya B. Zavaliy, Mihail M. Pockhveriya   +5 more
core   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Permanent Neurological Damage Due To Trauma: An Important Conclusion in Forensic Medicine

, 2013
Purpose: It is aimed to evaluate the demographic, etiological and clinical findings of the victims who were sent to Council of Forensic Medicine by the court of law and prosecutor's office and in whom permanent neurological disorders was diagnosed ...
Kumral, Bahadır, Oğuz, Keriman, Gündoğmuş, Ümit Naci, Ünal, Aysun   +3 more
core  

Sleep disorders in neurological practice [PDF]

, 2012
Sleep disorders are closely associated with both nervous system diseases and mental disorders; however, such patients prefer to seek just neurological advice. Insomnia is the most common complaint in routine clinical practice.
Mikhail Guryevich Poluektov
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis

Journal of Translational Medicine
Background Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by fluctuating muscle weakness. Despite the availability of established therapies, the management of MG symptoms remains suboptimal, partially attributed to lack of efficacy
Jiao Li, Fei Wang, Zhen Li, Jingjing Feng, Yi Men, Jinming Han, Jiangwei Xia, Chen Zhang, Yilai Han, Teng Chen, Yinan Zhao, Sirui Zhou, Yuwei Da, Guoliang Chai, Junwei Hao   +14 more
doaj   +1 more source

“Shake-Shake”: A new neurological syndrome or a functional neurological disorder? [PDF]

Neuropsychiatric disorders are common neurological presentations that can pose a major diagnostic challenge in general medical practice. Functional neurological disorder presents with medical symptoms that can easily remain unrecognised or get ...
Cathy Abbo, Emmanuel Mpamizo, Emmanuel Musana, Neil Scolding   +3 more
core   +1 more source